TIP137 ADELA: Двойное слепое плацебо-контролируемое рандомизированное исследование III фазы элацестранта + эверолимуса против элацестранта + плацебо у пациенток с распространенным раком молочной железы (РМЖ) ER+/HER2- с мутацией гена ESR1, прогрессирующим на фоне эндокринной терапии – CancerNetwork
TIP137 ADELA: A Double-blind, Placebo-Controlled, Randomized Phase 3 Trial of Elacestrant + Ever…
该文章暂未提取到完整正文，已从资讯列表和商品关联资讯中自动隐藏。你可以返回文章列表继续浏览其他内容。
よくある質問
Which products are related to this article?
No strongly related product has been identified yet. The match updates automatically when the article or catalog changes.
How can I view the medicines discussed in this article?
Use the related product cards below the article to review available specifications, prices, product information, and reviews.
Does this article replace advice from a doctor or pharmacist?
No. This content is for general information and health education only. Follow the prescription and individual guidance provided by qualified healthcare professionals.
